Overview
Blackrock Neurotech pioneered the implantable neurotech space, with the first implantable brain-computer interface in humans. Our products empower research, design, and clinical translation across the neuroscience, engineering, prosthetics, and medical communities. With more than 500 top institutional partners, our collaborations have resulted in thousands of published studies and groundbreaking innovations in wireless technology, flexible electrodes, and higher-density recordings. Blackrock also has the world’s largest portfolio of FDA- and CE-cleared products for human clinical research. Blackrock serves as a collaborative development partner for medical device companies looking to bring novel neurological and neurosurgical products to market in different therapy areas, including epilepsy. For more information on how we can help with your product, research, regulatory or clinical needs, visit www.blackrockneurotech.com.
Blackrock Neurotech pioneered the implantable neurotech space, with the first implantable brain-computer interface in humans, and has the world’s largest portfolio of FDA-cleared Brain-Computer Interface (BCI) products. With their deep BCI experience, Blackrock serves as a collaborative development partner for medical device companies looking to bring novel neurological and neurosurgical products to market in different therapy areas, including epilepsy.